Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 3 studies | 29% ± 11% |
Insufficient scRNA-seq data for expression of ARHGAP33 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 5390.69 | 2639 / 2642 | 100% | 45.18 | 704 / 705 |
ovary | 100% | 4781.88 | 180 / 180 | 93% | 15.77 | 402 / 430 |
uterus | 100% | 3733.68 | 170 / 170 | 92% | 13.85 | 421 / 459 |
adrenal gland | 94% | 1462.53 | 242 / 258 | 96% | 13.67 | 221 / 230 |
breast | 98% | 2292.27 | 449 / 459 | 88% | 9.14 | 982 / 1118 |
prostate | 99% | 2466.88 | 242 / 245 | 86% | 6.48 | 433 / 502 |
esophagus | 94% | 1551.24 | 1354 / 1445 | 89% | 8.44 | 162 / 183 |
bladder | 100% | 1735.52 | 21 / 21 | 79% | 7.05 | 400 / 504 |
pancreas | 91% | 1116.68 | 299 / 328 | 88% | 6.61 | 157 / 178 |
thymus | 100% | 3867.27 | 650 / 653 | 74% | 7.84 | 447 / 605 |
intestine | 99% | 1912.36 | 953 / 966 | 72% | 5.00 | 382 / 527 |
stomach | 93% | 1539.58 | 334 / 359 | 78% | 5.39 | 222 / 286 |
kidney | 97% | 1644.85 | 86 / 89 | 63% | 5.21 | 571 / 901 |
skin | 85% | 1415.09 | 1533 / 1809 | 75% | 5.37 | 353 / 472 |
lung | 90% | 1289.61 | 518 / 578 | 69% | 6.11 | 794 / 1155 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.25 | 1 / 1 |
spleen | 99% | 2010.50 | 239 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 2206.66 | 1317 / 1335 | 0% | 0 | 0 / 0 |
adipose | 93% | 1476.65 | 1121 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 6.97 | 25 / 29 |
tonsil | 0% | 0 | 0 / 0 | 82% | 8.77 | 37 / 45 |
liver | 31% | 266.70 | 70 / 226 | 43% | 2.84 | 174 / 406 |
heart | 57% | 583.72 | 489 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 49% | 696.32 | 451 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 15% | 0.75 | 12 / 80 |
muscle | 11% | 91.64 | 87 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0015031 | Biological process | protein transport |
GO_0009636 | Biological process | response to toxic substance |
GO_0061001 | Biological process | regulation of dendritic spine morphogenesis |
GO_0007264 | Biological process | small GTPase-mediated signal transduction |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005938 | Cellular component | cell cortex |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0043197 | Cellular component | dendritic spine |
GO_0005886 | Cellular component | plasma membrane |
GO_0001650 | Cellular component | fibrillar center |
GO_0019901 | Molecular function | protein kinase binding |
GO_0005515 | Molecular function | protein binding |
GO_0035091 | Molecular function | phosphatidylinositol binding |
GO_0005096 | Molecular function | GTPase activator activity |
Gene name | ARHGAP33 |
Protein name | Rho GTPase-activating protein 33 (Rho-type GTPase-activating protein 33) (Sorting nexin-26) (Tc10/CDC42 GTPase-activating protein) Rho GTPase-activating protein 33 Rho GTPase activating protein 33 |
Synonyms | TCGAP SNX26 |
Description | FUNCTION: May be involved in several stages of intracellular trafficking. Could play an important role in the regulation of glucose transport by insulin. May act as a downstream effector of RHOQ/TC10 in the regulation of insulin-stimulated glucose transport (By similarity). . |
Accessions | ENST00000007510 O14559 ENST00000590893.5 K7EK14 A0A0A0MQQ9 ENST00000007510.9 [O14559-1] ENST00000588248.6 K7EQI6 ENST00000314737.9 [O14559-11] ENST00000378944.9 [O14559-10] |